Vanguard PRIMECAP Fund Investor Shares (VPMCX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
171.06
-0.02 (-0.01%)
Sep 18, 2024, 8:06 AM EDT
13.24% (1Y)
Fund Assets | 77.22B |
Expense Ratio | 0.38% |
Min. Investment | $3,000 |
Turnover | 4.00% |
Dividend (ttm) | 10.81 |
Dividend Yield | 6.23% |
Dividend Growth | -13.11% |
Payout Frequency | Annual |
Ex-Dividend Date | Dec 19, 2023 |
Previous Close | 171.08 |
YTD Return | 13.32% |
1-Year Return | 21.33% |
5-Year Return | 92.85% |
52-Week Low | 139.62 |
52-Week High | 179.80 |
Beta (5Y) | 0.95 |
Holdings | 169 |
Inception Date | Oct 31, 1984 |
About VPMCX
The fund invests in stocks considered to have above-average earnings growth potential that is not reflected in their current market prices. Its portfolio consists predominantly of large- and mid-capitalization stocks.
Fund Family Vanguard
Category Large Blend
Performance Rating Above Average
Risk Rating Average
Stock Exchange NASDAQ
Ticker Symbol VPMCX
Index S&P 500 TR
Performance
VPMCX had a total return of 21.33% in the past year. Since the fund's inception, the average annual return has been 14.53%, including dividends.
Other Share Classes
These are alternative share classes of the same fund, from the same provider.
Symbol | Share Class | Expense Ratio |
---|---|---|
VPMAX | Admiral Shares | 0.31% |
Top 10 Holdings
41.83% of assetsName | Symbol | Weight |
---|---|---|
Eli Lilly and Company | LLY | 13.29% |
Micron Technology, Inc. | MU | 3.96% |
Amgen Inc. | AMGN | 3.56% |
KLA Corporation | KLAC | 3.52% |
Microsoft Corporation | MSFT | 3.44% |
FedEx Corporation | FDX | 3.24% |
Adobe Inc. | ADBE | 2.96% |
Biogen Inc. | BIIB | 2.69% |
Texas Instruments Incorporated | TXN | 2.62% |
Alphabet Inc. | GOOGL | 2.55% |
Dividend History
Ex-Dividend | Amount | Pay Date |
---|---|---|
Dec 19, 2023 | $10.80759 | Dec 20, 2023 |
Dec 19, 2022 | $12.43852 | Dec 20, 2022 |
Dec 20, 2021 | $16.4863 | Dec 21, 2021 |
Dec 21, 2020 | $14.4569 | Dec 22, 2020 |
Dec 17, 2019 | $9.9518 | Dec 18, 2019 |
Dec 18, 2018 | $9.709 | Dec 19, 2018 |